Filing Details

 

	UNITED STATES
	SECURITIES AND EXCHANGE COMMISSION
	Washington, D.C. 20549

SCHEDULE 13G/A

 

Under the Securities Exchange Act of 1934
(Amendment No. 2)*

 

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o	Rule 13d-1(b)
x	Rule 13d-1(c)
o	Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

CUSIP No.  53630X104
	1.	Name of Reporting Persons Venrock Healthcare Capital Partners, L.P.
	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		x(1)
		(b)		o
	3.	SEC Use Only
	4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:			5.		Sole Voting Power 0
			6.		Shared Voting Power 1,169,921(2)
			7.		Sole Dispositive Power 0
			8.		Shared Dispositive Power 1,169,921(2)
	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,169,921(2)
	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
	11.	Percent of Class Represented by Amount in Row (9) 5.5%(3)
	12.	Type of Reporting Person (See Instructions) PN

 

(1)         Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

 

(2)         Consists of 661,912 shares owned by Venrock Healthcare Capital Partners, L.P., 121,081 shares owned by VHCP Co-Investment Holdings, LLC, 275,313 shares owned by Venrock Healthcare Capital Partners II, L.P. and 111,615 shares owned by VHCP Co-Investment Holdings II, LLC.

 

(3)         This percentage is calculated based upon 21,196,537 shares of the Issuers common stock outstanding as of November 8, 2017, as set forth in the Issuers Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 8, 2017.

 

2

 

CUSIP No. 53630X104
	1.	Name of Reporting Persons VHCP Co-Investment Holdings, LLC
	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		x(1)
		(b)		o
	3.	SEC Use Only
	4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:			5.		Sole Voting Power 0
			6.		Shared Voting Power 1,169,921(2)
			7.		Sole Dispositive Power 0
			8.		Shared Dispositive Power 1,169,921(2)
	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,169,921(2)
	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
	11.	Percent of Class Represented by Amount in Row (9) 5.5%(3)
	12.	Type of Reporting Person (See Instructions) OO

 

(1)         Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

 

(2)         Consists of 661,912 shares owned by Venrock Healthcare Capital Partners, L.P., 121,081 shares owned by VHCP Co-Investment Holdings, LLC, 275,313 shares owned by Venrock Healthcare Capital Partners II, L.P. and 111,615 shares owned by VHCP Co-Investment Holdings II, LLC.

 

(3)         This percentage is calculated based upon 21,196,537 shares of the Issuers common stock outstanding as of November 8, 2017, as set forth in the Issuers Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 8, 2017.

 

3

 

CUSIP No. 53630X104
	1.	Name of Reporting Persons Venrock Healthcare Capital Partners II, L.P.
	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		x(1)
		(b)		o
	3.	SEC Use Only
	4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:			5.		Sole Voting Power 0
			6.		Shared Voting Power 1,169,921(2)
			7.		Sole Dispositive Power 0
			8.		Shared Dispositive Power 1,169,921(2)
	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,169,921(2)
	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
	11.	Percent of Class Represented by Amount in Row (9) 5.5%(3)
	12.	Type of Reporting Person (See Instructions) PN

 

(1)         Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

 

(2)         Consists of 661,912 shares owned by Venrock Healthcare Capital Partners, L.P., 121,081 shares owned by VHCP Co-Investment Holdings, LLC, 275,313 shares owned by Venrock Healthcare Capital Partners II, L.P. and 111,615 shares owned by VHCP Co-Investment Holdings II, LLC.

 

(3)         This percentage is calculated based upon 21,196,537 shares of the Issuers common stock outstanding as of November 8, 2017, as set forth in the Issuers Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 8, 2017.

 

4

 

CUSIP No. 53630X104
	1.	Name of Reporting Persons VHCP Co-Investment Holdings II, LLC
	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		x(1)
		(b)		o
	3.	SEC Use Only
	4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:			5.		Sole Voting Power 0
			6.		Shared Voting Power 1,169,921(2)
			7.		Sole Dispositive Power 0
			8.		Shared Dispositive Power 1,169,921(2)
	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,169,921(2)
	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
	11.	Percent of Class Represented by Amount in Row (9) 5.5%(3)
	12.	Type of Reporting Person (See Instructions) OO

 

(1)         Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

 

(2)         Consists of 661,912 shares owned by Venrock Healthcare Capital Partners, L.P., 121,081 shares owned by VHCP Co-Investment Holdings, LLC, 275,313 shares owned by Venrock Healthcare Capital Partners II, L.P. and 111,615 shares owned by VHCP Co-Investment Holdings II, LLC.

 

(3)         This percentage is calculated based upon 21,196,537 shares of the Issuers common stock outstanding as of November 8, 2017, as set forth in the Issuers Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 8, 2017.

 

5

 

CUSIP No. 53630X104
	1.	Name of Reporting Persons VHCP Management, LLC
	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		x(1)
		(b)		o
	3.	SEC Use Only
	4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:			5.		Sole Voting Power 0
			6.		Shared Voting Power 1,169,921(2)
			7.		Sole Dispositive Power 0
			8.		Shared Dispositive Power 1,169,921(2)
	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,169,921(2)
	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
	11.	Percent of Class Represented by Amount in Row (9) 5.5%(3)
	12.	Type of Reporting Person (See Instructions) OO

 

(1)         Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

 

(2)         Consists of 661,912 shares owned by Venrock Healthcare Capital Partners, L.P., 121,081 shares owned by VHCP Co-Investment Holdings, LLC, 275,313 shares owned by Venrock Healthcare Capital Partners II, L.P. and 111,615 shares owned by VHCP Co-Investment Holdings II, LLC.

 

(3)         This percentage is calculated based upon 21,196,537 shares of the Issuers common stock outstanding as of November 8, 2017, as set forth in the Issuers Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 8, 2017.

 

6

 

CUSIP No. 53630X104
	1.	Name of Reporting Persons VHCP Management II, LLC
	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		x(1)
		(b)		o
	3.	SEC Use Only
	4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:			5.		Sole Voting Power 0
			6.		Shared Voting Power 1,169,921(2)
			7.		Sole Dispositive Power 0
			8.		Shared Dispositive Power 1,169,921(2)
	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,169,921(2)
	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
	11.	Percent of Class Represented by Amount in Row (9) 5.5%(3)
	12.	Type of Reporting Person (See Instructions) OO

 

(1)         Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

 

(2)         Consists of 661,912 shares owned by Venrock Healthcare Capital Partners, L.P., 121,081 shares owned by VHCP Co-Investment Holdings, LLC, 275,313 shares owned by Venrock Healthcare Capital Partners II, L.P. and 111,615 shares owned by VHCP Co-Investment Holdings II, LLC.

 

(3)         This percentage is calculated based upon 21,196,537 shares of the Issuers common stock outstanding as of November 8, 2017, as set forth in the Issuers Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 8, 2017.

 

7

 

CUSIP No. 53630X104
	1.	Name of Reporting Persons Shah, Nimish
	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		x(1)
		(b)		o
	3.	SEC Use Only
	4.	Citizenship or Place of Organization United States
Number of Shares Beneficially Owned by Each Reporting Person With:			5.		Sole Voting Power 0
			6.		Shared Voting Power 1,169,921(2)
			7.		Sole Dispositive Power 0
			8.		Shared Dispositive Power 1,169,921(2)
	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,169,921(2)
	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
	11.	Percent of Class Represented by Amount in Row (9) 5.5%(3)
	12.	Type of Reporting Person (See Instructions) IN

 

(1)         Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

 

(2)         Consists of 661,912 shares owned by Venrock Healthcare Capital Partners, L.P., 121,081 shares owned by VHCP Co-Investment Holdings, LLC, 275,313 shares owned by Venrock Healthcare Capital Partners II, L.P. and 111,615 shares owned by VHCP Co-Investment Holdings II, LLC.

 

(3)         This percentage is calculated based upon 21,196,537 shares of the Issuers common stock outstanding as of November 8, 2017, as set forth in the Issuers Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 8, 2017.

 

8

 

CUSIP No. 53630X104
	1.	Name of Reporting Persons Koh, Bong
	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		x(1)
		(b)		o
	3.	SEC Use Only
	4.	Citizenship or Place of Organization United States
Number of Shares Beneficially Owned by Each Reporting Person With:			5.		Sole Voting Power 0
			6.		Shared Voting Power 1,169,921(2)
			7.		Sole Dispositive Power 0
			8.		Shared Dispositive Power 1,169,921(2)
	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,169,921(2)
	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
	11.	Percent of Class Represented by Amount in Row (9) 5.5%(3)
	12.	Type of Reporting Person (See Instructions) IN

 

(1)         Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

 

(2)         Consists of 661,912 shares owned by Venrock Healthcare Capital Partners, L.P., 121,081 shares owned by VHCP Co-Investment Holdings, LLC, 275,313 shares owned by Venrock Healthcare Capital Partners II, L.P. and 111,615 shares owned by VHCP Co-Investment Holdings II, LLC.

 

(3)         This percentage is calculated based upon 21,196,537 shares of the Issuers common stock outstanding as of November 8, 2017, as set forth in the Issuers Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 8, 2017.

 

9

 

CUSIP No.53630X104

 

Introductory Note: This Schedule 13G/A is filed on behalf of Venrock Healthcare Capital Partners, L.P., a limited partnership organized under the laws of the State of Delaware (VHCP LP), VHCP Co-Investment Holdings, LLC, a limited liability company organized under the laws of the State of Delaware (VHCP Co-Investment), Venrock Healthcare Capital Partners II, L.P., a limited partnership organized under the laws of the State of Delaware (VHCP II LP), VHCP Co-Investment Holdings II, LLC, a limited liability company organized under the laws of the State of Delaware (VHCP Co-Investment II), VHCP Management, LLC, a limited liability company organized under the laws of the State of Delaware (VHCP Management), VHCP Management II, LLC, a limited liability company organized under the laws of the State of Delaware (VHCP Management II and collectively with VHCP LP, VHCP II LP, VHCP Co-Investment II, VHCP Management and VHCP Co-Investment, the Venrock Entities), Nimish Shah (Shah) and Bong Koh (Koh) in respect of Common Stock of Lipocine Inc.

 

Item 1.
	(a)	Name of Issuer Lipocine Inc.
	(b)	Address of Issuers Principal Executive Offices 675 Arapeen Drive Suite 202 Salt Lake City, Utah 84108
Item 2.
	(a)	Name of Person Filing Venrock Healthcare Capital Partners, L.P. VHCP Co-Investment Holdings, LLC Venrock Healthcare Capital Partners II, L.P. VHCP Co-Investment Holdings II, LLC VHCP Management, LLC VHCP Management II, LLC Nimish Shah Bong Koh
	(b)	Address of Principal Business Office or, if none, Residence

 

New York Office:	Palo Alto Office:	Boston Office:
530 Fifth Avenue	3340 Hillview Avenue	34 Farnsworth Street
22nd Floor	Palo Alto, CA 94304	3rd Floor
New York, NY 10036		Boston, MA 02210

 

	(c)	Citizenship All entities were organized in Delaware. The individuals are both United States citizens.
	(d)	Title of Class of Securities Common Stock
	(e)	CUSIP Number 53630X104
Item 3.	If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
Not applicable

 

10

 

CUSIP No.53630X104

 

Item 4.

Ownership

 

(a)   Amount beneficially owned as of December 31, 2017:

 

 

(b)   Percent of class as of December 31, 2017:

 

 

(c)   Number of shares as to which the person has, as of December 31, 2017:

 

(i)    Sole power to vote or to direct the vote

 

 

(ii)   Shared power to vote or to direct the vote

 

 

(iii)  Sole power to dispose or to direct the disposition of

 

 

(iv)  Shared power to dispose or to direct the disposition of

 

 

 

 

 

(1)

These shares are owned directly as follows: 661,912 shares are owned by Venrock Healthcare Capital Partners, L.P., 121,081 shares are owned by VHCP Co-Investment Holdings, LLC, 275,313 shares are owned by Venrock Healthcare Capital Partners II, L.P. and 111,615 shares are owned by VHCP Co-Investment Holdings II, LLC. VHCP Management, LLC is the general partner of Venrock Healthcare Capital Partners, L.P. and the manager of VHCP Co-Investment Holdings, LLC. VHCP Management II, LLC is the general partner of Venrock Healthcare Capital Partners II, L.P. and the manager of VHCP Co-Investment Holdings II, LLC. Messrs. Shah and Koh are the managing members of VHCP Management, LLC and VHCP Management II, LLC.

 

11

 

CUSIP No.53630X104

 

Item 5.	Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following   o.
Item 6.	Ownership of More than Five Percent on Behalf of Another Person
Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
Not Applicable
Item 8.	Identification and Classification of Members of the Group
Not Applicable
Item 9.	Notice of Dissolution of a Group
Not Applicable

 

12

 

CUSIP No. 53630X104

 

Item 10.	Certification
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 13, 2018

 

Venrock Healthcare Capital Partners, L.P.				Venrock Healthcare Capital Partners II, L.P.
By:	VHCP Management, LLC			By:	VHCP Management II, LLC
Its:	General Partner			Its:	General Partner
By:	/s/ David L. Stepp			By:	/s/ David L. Stepp
	Name:	David L. Stepp			Name:	David L. Stepp
	Its:	Authorized Signatory			Its:	Authorized Signatory
VHCP Co-Investment Holdings, LLC				VHCP Co-Investment Holdings II, LLC
By:	VHCP Management, LLC			By:	VHCP Management II, LLC
Its:	Manager			Its:	Manager
By:	/s/ David L. Stepp			By:	/s/ David L. Stepp
	Name:	David L. Stepp			Name:	David L. Stepp
	Its:	Authorized Signatory			Its:	Authorized Signatory
VHCP Management, LLC				VHCP Management II, LLC
By:	/s/ David L. Stepp			By:	/s/ David L. Stepp
	Name:	David L. Stepp			Name:	David L. Stepp
	Its:	Authorized Signatory			Its:	Authorized Signatory
Nimish Shah				Bong Koh
By:	/s/ David L. Stepp			By:	/s/ David L. Stepp
	David L. Stepp, as attorney-in-fact				David L. Stepp, as attorney-in-fact

 

13

 

CUSIP No. 53630X104

 

EXHIBITS

 

A:		Joint Filing Agreement
B:		Power of Attorney for Nimish Shah
C:		Power of Attorney for Bong Koh (Incorporated by reference from Exhibit C to Schedule 13G filed on February 13, 2015)

 

14

 

EXHIBIT A

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of Lipocine Inc. and further agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.

 

In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 13th day of February, 2017.

 

Venrock Healthcare Capital Partners, L.P.				Venrock Healthcare Capital Partners II, L.P.
By:	VHCP Management, LLC			By:	VHCP Management II, LLC
Its:	General Partner			Its:	General Partner
By:	/s/ David L. Stepp			By:	/s/ David L. Stepp
	Name:	David L. Stepp			Name:	David L. Stepp
	Its:	Authorized Signatory			Its:	Authorized Signatory
VHCP Co-Investment Holdings, LLC				VHCP Co-Investment Holdings II, LLC
By:	VHCP Management, LLC			By:	VHCP Management II, LLC
Its:	Manager			Its:	Manager
By:	/s/ David L. Stepp			By:	/s/ David L. Stepp
	Name:	David L. Stepp			Name:	David L. Stepp
	Its:	Authorized Signatory			Its:	Authorized Signatory
VHCP Management, LLC				VHCP Management II, LLC
By:	/s/ David L. Stepp			By:	/s/ David L. Stepp
	Name:	David L. Stepp			Name:	David L. Stepp
	Its:	Authorized Signatory			Its:	Authorized Signatory
Nimish Shah				Bong Koh
By:	/s/ David L. Stepp			By:	/s/ David L. Stepp
	David L. Stepp, as attorney-in-fact				David L. Stepp, as attorney-in-fact

 

 

EXHIBIT B

 

POWER OF ATTORNEY FOR NIMISH SHAH

 

KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints each of David L. Stepp, Sherman G. Souther and Lisa D. Harris signing individually, the undersigneds true and lawful attorney-in fact and agent to:

 

(i)                                   prepare execute and file, for and on behalf of the undersigned, any and all documents and filings that are required or advisable to be made with the United States Securities and Exchange Commission, any stock exchange or similar authority, under the Securities Exchange Act of 1934, as amended (the Exchange Act), and the rules and regulations promulgated thereunder, including without limitation (a) any Joint Filing Agreement under Rule 13d-1(k) of the Exchange Act (or any successor provision thereunder), Schedule 13D and Schedule 13G (or any successor schedules or forms adopted under the Exchange Act ) and any amendments thereto in accordance with Section 13 of the Exchange Act and the rules thereunder, and (b) Forms 3, 4 and 5 and any amendments thereto in accordance with Section 16(a) of the Exchange Act and the rules thereunder; and

 

(ii)                                take any other action of any nature whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-facts discretion.

 

The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-facts substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of undersigned, is not assuming, nor is Venrock assuming, any of the undersigneds responsibilities to comply with the Exchange Act, including without limitation Sections 13 and 16 of the Exchange Act.

 

This power of Attorney shall remain in full force and effect until the earliest to occur of (a) the undersigned is no longer required to file any form or document with respect to the undersigneds holdings of and transactions in securities issued by a company, (b) revocation by the undersigned in a signed writing delivered to the foregoing attorney-in-fact, or (c) until such attorney-in-fact shall no longer be employed by VR Management, LLC (or its successor).

 

IN WITNESS WHEREOF, the undersigned has cause this Power of Attorney to be executed as of this 13th  day of February, 2017.

 

/s/ Nimish Shah